Balance of bacterial and fungal disrupted by inhaler.

Unlocking the Mystery: How Inhaled Antibiotics Impact Fungal Growth in Cystic Fibrosis

Lena Kashyap in Health & Wellness December 2025 • 4 min read.

"A groundbreaking study reveals the unexpected link between inhaled antibiotic use and Scedosporium/Lomentospora species isolation in cystic fibrosis patients, paving the way for new treatment strategies."

Cystic fibrosis (CF) is a genetic condition affecting around 30,000 people in the United States. It causes problems with how chloride—a component of salt—moves in and out of cells, leading to thick mucus buildup in the lungs and other organs. This can cause major health issues, especially lung infections, which are a primary concern for most people with CF.

When dealing with CF, long-term lung infections can cause extensive damage, leading to breathing difficulties and, ultimately, respiratory failure. Traditionally, these infections have been blamed on bacteria like Pseudomonas aeruginosa, Burkholderia cepacia, and Staphylococcus aureus. However, recent studies indicate that fungal infections are becoming increasingly common in CF patients.

Among these fungi, Scedosporium species (spp) is the second most common mold found in the lungs of CF patients, after Aspergillus. Despite this, we don't fully understand the factors that lead to Scedosporium infections or their overall impact on patient health. Researchers are keen to learn more about these connections to improve treatment strategies and outcomes for individuals with CF.

The Surprising Role of Inhaled Antibiotics: What the Research Shows

Balance of bacterial and fungal disrupted by inhaler.

A recent study has shed light on the possible role of inhaled antibiotics in the growth of Scedosporium. The researchers analyzed data from the Cystic Fibrosis Foundation Patient Registry, looking at patients followed between 2010 and 2012. They discovered a notable link between the use of inhaled antibiotics and the isolation of Scedosporium species in these individuals.

Specifically, the study found that patients who used inhaled antibiotics were twice as likely to have Scedosporium isolated from their respiratory samples. This suggests that while these antibiotics are essential for controlling bacterial infections, they may inadvertently create an environment in the lungs that encourages fungal growth.

Older Age: Older patients were more likely to have Scedosporium isolated. For every 10-year increase in age, there was a 16% increase in the odds of Scedosporium isolation.
Race: White individuals had a 69% higher chance of Scedosporium isolation compared to non-white individuals.
Inhaled Antibiotics: The use of inhaled antibiotics doubled the likelihood of Scedosporium isolation.
Intravenous Antibiotics: For each additional course of intravenous antibiotics, the odds of Scedosporium isolation increased by 8%.

These findings suggest that the balance of microorganisms in the CF lung is delicate and can be disrupted by antibiotic use. By reducing the presence of bacteria, antibiotics may allow fungi like Scedosporium to thrive, potentially leading to new challenges in managing CF-related lung disease.

What Does This Mean for CF Treatment?

The discovery of this link between inhaled antibiotics and Scedosporium isolation opens new avenues for research and treatment strategies in cystic fibrosis. It highlights the need for a more holistic approach to managing CF lung disease, considering not only bacterial infections but also the potential impact on fungal growth. Future studies could explore ways to minimize the risk of fungal infections in patients requiring long-term antibiotic therapy.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What is the connection between inhaled antibiotics and Scedosporium infections in cystic fibrosis patients?

A recent study found a significant link between the use of inhaled antibiotics and the isolation of Scedosporium species in individuals with cystic fibrosis (CF). Patients using inhaled antibiotics were twice as likely to have Scedosporium identified in their respiratory samples. This suggests that inhaled antibiotics, while combating bacterial infections, may inadvertently foster an environment in the lungs that promotes the growth of fungi like Scedosporium.

Besides inhaled antibiotics, what other factors influence the likelihood of Scedosporium isolation in CF patients?

The study highlighted several factors, besides inhaled antibiotics, associated with a higher chance of Scedosporium isolation. Older age was a factor; for every ten-year increase in age, the odds of Scedosporium isolation increased by 16%. Race also played a role, with white individuals showing a 69% higher likelihood of Scedosporium isolation compared to non-white individuals. Additionally, each additional course of intravenous antibiotics was associated with an 8% increase in the odds of Scedosporium isolation.

Why is understanding Scedosporium important in the context of Cystic Fibrosis?

Scedosporium species are the second most common mold found in the lungs of CF patients, following Aspergillus. CF is characterized by thick mucus buildup in the lungs, creating an environment conducive to infections. Long-term lung infections can cause extensive damage, leading to breathing difficulties. While bacteria like Pseudomonas aeruginosa, Burkholderia cepacia, and Staphylococcus aureus have traditionally been the primary concern, the increasing prevalence of fungal infections, particularly Scedosporium, necessitates a deeper understanding to improve treatment strategies and patient outcomes.

How might the study findings change the approach to treating cystic fibrosis?

The discovery of a link between inhaled antibiotics and Scedosporium isolation opens new avenues for research and treatment strategies. This highlights the need for a more holistic approach to managing CF lung disease. Future studies could focus on minimizing the risk of fungal infections in patients requiring long-term antibiotic therapy, potentially involving the use of antifungal medications or alternative antibiotic strategies to maintain a balanced lung microbiome. This could lead to better management of lung health in CF patients.

What are the implications of the findings on inhaled antibiotics for individuals with cystic fibrosis?

The findings suggest that while inhaled antibiotics are crucial for controlling bacterial infections in CF, their use could inadvertently promote fungal growth, specifically Scedosporium. This implies that healthcare providers need to consider the potential for fungal infections when prescribing long-term antibiotic therapies. The implications involve the possibility of developing or worsening fungal lung infections, which could complicate the management of CF-related lung disease. The results emphasize the importance of balancing antibiotic use with strategies to prevent or treat fungal infections, potentially through the use of antifungal medications or alternative antibiotic treatment approaches.